Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Meningeal Neoplasms × Nivolumab × Clear all

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 49 Carcinoma, Non-Small-Cell Lung 34 Carcinoma, Renal Cell 26 Neoplasms 13 Neoplasm Metastasis 13 Lung Neoplasms 12 Stomach Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 11 Carcinoma, Hepatocellular 11 Adenocarcinoma Of Esophagus 11 Colorectal Neoplasms 10 Hodgkin Disease 7 Esophageal Neoplasms 7 Carcinoma, Transitional Cell 7 Skin Neoplasms 6 Sarcoma 6 Brain Neoplasms 6 Triple Negative Breast Neoplasms 5 Recurrence 5 Kidney Neoplasms 5 Esophageal Squamous Cell Carcinoma 5 Clear-cell metastatic renal cell carcinoma 5 Carcinoma, Merkel Cell 5 Breast Neoplasms 5 Uterine Cervical Neoplasms 4 Prostatic Neoplasms 4 Pancreatic Neoplasms 4 Multiple Myeloma 4 Glioblastoma 4 Colonic Neoplasms 4

Interventions

Trastuzumab 3 tucatinib 2 Radiotherapy 2 Capecitabine 2 pertuzumab 1 Nivolumab 1 Methotrexate 1 Blood Specimen Collection 1 AZD1390 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05112549 2025-04-03

IT-PD1

University Hospital Tuebingen

Phase 1 Recruiting

Meningeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡